[1]
Yamazhan, T. et al. 2020. Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. Turkish Journal of Gastroenterology. 31, 3 (Jan. 2020), 239–245. DOI:https://doi.org/10.5152/tjg.2020.19076.